CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature.
Saved in:
| Title: | CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature. |
|---|---|
| Authors: | Li G; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, China.; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China., Kang J; Department of Clinical Laboratory, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China., Li X; Department of Blood Transfusion, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China., Zhao L; Department of Pathology, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China., Chen Y; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China., Gong C; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, China., Liu Z; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, China., Zhang B; Department of Blood Transfusion, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jan 26; Vol. 15, pp. 1661650. Date of Electronic Publication: 2026 Jan 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
